HCA控股 HCA 深 沪
等待开盘 12-18 09:30:00 美东时间
471.85
+2.060
+0.44%
华盛通- 最 高471.99
- 今 开468.33
- 成交量 120.65万股
- 最 低 461.00
- 昨 收 469.79
- 总市值 1075.82亿
- 52周最高 519.28
- 市盈率 静 21.45
- 换手率 0.00%
- 52周最低 287.10
- 委 比 60.00%
- 总股本 2.28亿
- 历史最高 519.28
- 量 比 0.87
- 振 幅 2.34%
- 历史最低 -0.48
- 每 手 1
- 风险率 56.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
12-16 09:36
Elizabeth Warren Slams GOP For Leaving Families 'In the Dirt,' Warns Of Higher Costs As 'Last Chance' To Save ACA Subsidies Fails
Elizabeth Warren slams GOP for blocking ACA subsidies, warning of spiking healthcare costs and leaving American families "in the dirt."
12-12 16:42
Here's How Much $1000 Invested In HCA Healthcare 10 Years Ago Would Be Worth Today
HCA Healthcare (NYSE:HCA) has outperformed the market over the past 10 years by...
11-29 04:30
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
If You Invested $100 In HCA Healthcare Stock 10 Years Ago, You Would Have This Much Today
HCA Healthcare (NYSE:HCA) has outperformed the market over the past 10 years by...
11-13 06:45
Tech Rallies, Palantir Jumps 6% As Shutdown End Looms: What's Moving Markets Monday?
Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk assets amid encouraging signs from Washington that the record-long government shutdown may soon conclude.
11-11 01:31
Is the Market Bullish or Bearish on HCA Healthcare Inc?
HCA Healthcare Inc's (NYSE:HCA) short interest as a percent of float has fallen...
11-08 02:00
财报速睇 | HCA控股2025财年Q3营收191.61亿美元，股权持有人应占溢利16.43亿美元
华盛资讯10月31日讯，HCA Healthcare, Inc.公司今日公布2025财年Q3业绩，公司Q3营收191.61亿美元，同比增长9.6%，股权持有人应占溢利16.43亿美元，同比增长29.4%。
10-31 05:13
和铂医药-B午前涨逾4% 发布首个全人源HCAb生成模型
和铂医药-B（02142）午前股价上涨3.98%，现报13.58港元，成交额6126.36万港元。 据和铂医药官微消息，10月28日，“智耀和铂 汇创星辰...
10-30 11:51
和铂医药发布全人源重链抗体（HCAb）生成和筛选模型
和铂医药全球研发日活动于中国上海成功举办。会上正式发布其Hu-mAtrIx™人工智能平台驱动的首个全人源AI HCAb模型——全人源重链抗体（HCAb）生成和筛...
10-29 16:48
